Literature DB >> 26595309

The role of selenium in insulin-like growth factor I receptor (IGF-IR) expression and regulation of apoptosis in mouse osteoblasts.

Gaixian Ren1, Tariq Ali1, Wei Chen1, Dandan Han1, Limei Zhang1, Xiaolong Gu1, Shiyao Zhang1, Laidi Ding1, Séamus Fanning2, Bo Han3.   

Abstract

Selenium (Se) is an essential component for animals and human beings. The chemoprotective role of Se, via the regulation of the cell cycle, stimulation of apoptosis and activation of some cytokines among others, is well known; however, the comprehensive effects of Se on the expression of IGF-IR and its regulation of apoptosis have not been investigated. Thus the aim of this study was to report on the effects that different concentrations of Se extert on body weight, blood serum IGF-IR levels and histopathology in mice; and on IGF-IR expression, proliferation and apoptosis in mouse osteoblasts. In vivo experiments showed a significant decrease in body weight, serum levels of IGF-IR and prominent toxicant effects on the liver, kidney, heart and spleen following the administration of defined concentrations of Se for 30 d. However, moderate levels (0.1 mg/kg) of Se gradually improved weight and serum IGF-IR. In vitro osteoblast experiments revealed that at concentrations of 5 × 10(-6) and 10(-5) mol/L Se, MTT activity decreased in comparison with control cells. Cell cycle, TEM and caspase-3 activity supported these observations including an increase in the sub-G1 phase and notable apoptosis in osteoblasts, along with a decrease in the expression of mRNA and protein levels of IGF-IR. Moreover, the MTT activity, mRNA and protein levels of IGF-IR in osteoblasts were decreased and caspase-3 activity was increased in siRNA groups as compared with non-siRNA groups. These data suggest that Se significantly affects IGF-IR expression, and that it contributes to the proliferation and regulation of apoptosis in osteoblasts.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apoptosis; IGF-IR; Mice; Osteoblast; Proliferation; Selenium

Mesh:

Substances:

Year:  2015        PMID: 26595309     DOI: 10.1016/j.chemosphere.2015.11.003

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  2 in total

1.  The rhenium(I)-diselenoether anticancer drug targets ROS, TGF-β1, VEGF-A, and IGF-1 in an in vitro experimental model of triple-negative breast cancers.

Authors:  Philippe Collery; Vijay Veena; Adhikesavan Harikrishnan; Didier Desmaele
Journal:  Invest New Drugs       Date:  2019-01-11       Impact factor: 3.850

2.  Increase in insulin-like growth factor 1 (IGF-1) and insulin-like growth factor binding protein 1 after supplementation with selenium and coenzyme Q10. A prospective randomized double-blind placebo-controlled trial among elderly Swedish citizens.

Authors:  Urban Alehagen; Peter Johansson; Jan Aaseth; Jan Alexander; Kerstin Brismar
Journal:  PLoS One       Date:  2017-06-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.